1. |
Aslam S, Musher DM. An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease. Gastroenterol Clin North Am, 2006, 35(2): 315-335.
|
2. |
Fekty R. Guidelines for the diagnosis and management of Clostri-dium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroen-terol, 1997, 92(5): 739-750.
|
3. |
Schulze M, Fritz J, Joanoviciu SD, 等. 假膜性结肠炎的CT诊断. 放射学实践, 2009, 24(5): 577-578.
|
4. |
王海红, 付蕾, 王昕, 等. 28例伪膜性肠炎的内镜及临床特点分析. 胃肠病学和肝病学杂志, 2012, 21(9): 807-809.
|
5. |
王一鸣, 熊毅敏, 郑国荣, 等. 伪膜性肠炎的内镜与临床特征研究. 中国内镜杂志, 2003, 9(5): 89-90.
|
6. |
陈荣, 罗燕萍, 叶丽艳, 等. 应用显色培养基快速检测血培养中耐甲氧西林金黄色葡萄球菌. 中华医院感染学杂志, 2012, 22(13): 2949-2951.
|
7. |
Lo TS, Borchardt SM. Antibiotic-associated diarrhea due to methici-llin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis, 2009, 63(4): 388-389.
|
8. |
Takesue Y, Yokoyama T, Kodama T, et al. A study on postoperative enteritis caused by methicillin-resistant Staphylococcus aureus. Surg Today, 1993, 23(1): 4-8.
|
9. |
Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the preven-tion and treatment of antibiotic-associated diarrhea a systematic review and meta-analysis. JAMA, 2012, 307(18): 1959-1969.
|
10. |
Song HJ, Shim KN, Jung SA, et al. Antibiotic-associated diarrhea: candidate organisms other than Clostridium difficile. Korean J Intern Med, 2008, 23(1): 9-15.
|
11. |
Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev, 2000, 13(1): 16-34.
|
12. |
Causey MW, Spencer MP, Steele SR. Clostridium difficile enteritis after colectomy. Am Surg, 2009, 75(12): 1203-1206.
|
13. |
Takeuchi K, Tsuzuki Y, Ando T, et al. Clinical studies of enteritis caused by methicillin-resistant Staphylococcus aureus. Eur J Surg, 2001, 167(4): 293-296.
|
14. |
张桂香, 陈汉忠, 罗志鸿, 等. 假膜性肠炎的CT诊断. 放射学实践, 2014, 29(4): 416-418.
|
15. |
陈颖, 蔡庆. 伪膜性结肠炎的CT表现. 中国CT和MRI杂志, 2011, 9(6): 13-15.
|
16. |
Gemmell CG, Edwards DI, Fraise AP, et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother, 2006, 57(4): 589-608.
|
17. |
李松, 肖桂元, 周甘平, 等. MRSA感染用药分析. 现代医院, 2008, 8(10): 19-21.
|
18. |
秦新裕, 吴文川. MRSA感染的治疗. 中国普外基础与临床杂志, 2010, 17(11): 1120-1122.
|
19. |
陈红旗, 杨俊, 周玉坤, 等. 益生菌对炎性肠病小鼠肠屏障功能的影响. 中国普外基础与临床杂志, 2011, 18(12): 1242-1247.
|
20. |
秦环龙, 陈红旗. 微生态制剂在炎症性肠病治疗中的应用. 中国实用外科杂志, 2013, 33(7): 546-549.
|
21. |
Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithe-lial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut, 2003, 52(7): 988-997.
|
22. |
Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha-and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology, 2006, 130(3): 731-746.
|
23. |
van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med, 2013, 368(5): 407-415.
|
24. |
肖咏梅, 王佳怡, 车艳然, 等. 粪便微生物移植治疗幼儿重症伪膜性肠炎1例并文献复习. 中国循证儿科杂志, 2014, 9(1): 37-40.
|
25. |
Ramsing BG, Arpi M, Andersen EA, et al. First outbreak with MRSA in a Danish neonatal intensive care unit: risk factors and control procedures. PLoS One, 2013, 8(6): e66904.
|